|
CSTF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.32509999972719E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.20280000404094E-08 |
| Normal-vs-Stage2 |
1.029030E-01 |
| Normal-vs-Stage3 |
8.181600E-01 |
| Normal-vs-Stage4 |
3.884200E-03 |
| Stage1-vs-Stage2 |
2.641600E-01 |
| Stage1-vs-Stage3 |
2.251900E-02 |
| Stage1-vs-Stage4 |
4.342200E-01 |
| Stage2-vs-Stage3 |
3.092200E-01 |
| Stage2-vs-Stage4 |
1.967230E-01 |
| Stage3-vs-Stage4 |
5.355900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.5329000003248E-07 |
| Normal-vs-AfricanAmerican |
2.32279999999863E-05 |
| Normal-vs-Asian |
7.083200E-01 |
| Caucasian-vs-AfricanAmerican |
7.148800E-01 |
| Caucasian-vs-Asian |
4.698400E-01 |
| AfricanAmerican-vs-Asian |
5.903800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.10389500160591E-11 |
| Normal-vs-Female |
8.883600E-01 |
| Male-vs-Female |
2.51969999998103E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.476350E-03 |
| Normal-vs-Extreme_Weight |
3.61299989926067E-10 |
| Normal-vs-Obese |
5.201700E-03 |
| Normal-vs-Extreme_Obese |
4.521400E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.407200E-01 |
| Normal_Weight-vs-Obese |
4.261000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.684200E-01 |
| Extreme_Weight-vs-Obese |
1.375910E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.921600E-01 |
| Obese-vs-Extreme_Obese |
2.068000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.341200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.622460E-04 |
| Normal-vs-Age(61-80Yrs) |
2.20350000468272E-08 |
| Normal-vs-Age(81-100Yrs) |
1.677620E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.544800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.317900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.464200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.226790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.283200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.578400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.80829795581872E-11 |
| Normal-VS-Type2 PRCC |
3.588300E-02 |
| Normal-VS-KIRP CIMP |
4.298200E-01 |
| Normal-VS-Unclassified PRCC |
2.582600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.441900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.022100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.789600E-04 |
| Type2 PRCC-VS-KIRP CIMP |
8.682200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.741200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.534000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.380300E-03 |
| Normal-vs-N1 |
4.495600E-01 |
| Normal-vs-N2 |
4.310000E-01 |
| N0-vs-N1 |
2.247400E-01 |
| N0-vs-N2 |
8.490000E-01 |
| N1-vs-N2 |
4.854000E-01 |
|
|
